查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1561565

2024-2032 年按药物类别、给药途径、配销通路和地区分類的犬异位性皮肤炎市场报告

Canine Atopic Dermatitis Market Report by Drug Class Type, Route of Administration, Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

2023年，全球犬异位性皮肤IMARC Group市场规模达21亿美元。

犬异位性皮肤炎（CAD）是一种由花粉、室内灰尘、昆虫叮咬、草和食物成分等过敏原引起的犬过敏性皮肤病。这是一种遗传倾向，通常影响六个月至三岁的狗。它通常影响动物的腹侧腹部、口腔、眼睛、指间皮肤、耳廓、腕骨、肘部和会阴区域。 CAD 的特征是出现多种症状，例如过度抓痒、爪子、腋下和脸部周围发炎和搔痒。可以透过免疫抑制剂、单克隆解剖学和糖皮质激素来治疗。它们可以透过口服、注射和局部用药的方式给药。众所周知，它在德国牧羊犬、拉布拉多犬、金毛猎犬和哈巴狗中非常普遍。

犬异位性皮肤炎市场趋势：

全球范围内家犬中 CAD 的发生率不断增加，这是创造积极市场前景的关键因素之一。这可以归因于环境条件的变化、空气污染水平的上升以及长期接触过敏原。此外，宠物主人对 CAD 早期症状和体征（如发红、皮肤油腻和酵母味）的日益关注和认识不断提高，正在推动市场成长。此外，单株抗体治疗该疾病的广泛采用也有利于市场成长。这些抗体有助于指导所需的免疫反应并平息疾病的传播。与此一致的是，越来越多的兽医、医院和诊所致力于为动物提供更好的护理，这对市场成长产生了积极影响。其他因素，包括政府实施各种限制在动物身上使用标籤外人类药物的倡议，以及兽医科学领域的广泛研究和开发（R＆D），预计将推动市场成长。

本报告回答的关键问题：

  • 迄今为止，全球犬异位性皮肤炎市场表现如何，未来几年又将如何表现？
  • COVID-19 对全球犬异位性皮肤炎市场有何影响？
  • 主要区域市场有哪些？
  • 根据药品类别类型，市场的细分情况如何？
  • 根据给药途径，市场的分化为何？
  • 基于配销通路的市场区隔是什么？
  • 产业价值链的各个阶段是什么？
  • 该行业的关键驱动因素和挑战是什么？
  • 全球犬异位性皮肤炎市场的结构如何？
  • 产业竞争程度如何？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球犬异位性皮肤炎市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场细分：依药物类别类型

  • 糖皮质激素
    • 市场趋势
    • 市场预测
  • 免疫抑制剂
    • 市场趋势
    • 市场预测
  • 单株抗体
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：依管理途径

  • 专题
    • 市场趋势
    • 市场预测
  • 口服
    • 市场趋势
    • 市场预测
  • 可注射
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：按配销通路

  • 兽医院
    • 市场趋势
    • 市场预测
  • 宠物诊所
    • 市场趋势
    • 市场预测
  • 药局和药局
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • AB Science
    • Bimeda Inc.
    • Bioceltix SA
    • Boehringer Ingelheim International GmbH
    • Ceva Sante Animale
    • Dechra Pharmaceuticals PLC
    • Elanco Animal Health Incorporated
    • Phibro Animal Health Corporation
    • Toray Industries Inc.
    • Vetoquinol SA
    • Virbac
    • Zoetis Inc.
Product Code: SR112024A4700

The global canine atopic dermatitis market size reached US$ 2.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.0 Billion by 2032, exhibiting a growth rate (CAGR) of 13.8% during 2024-2032.

Canine atopic dermatitis (CAD) is an allergic skin disease in dogs caused by allergens, such as pollens, house dust, insect bites, grass and food ingredients. It is an inherited predisposition that generally affects dogs aged between six months to three years. It commonly affects the ventral abdomen, mouth, eyes, interdigital skin, ear pinnae, carpal, elbow and perineal area of the animals. CAD is characterized by various symptoms, such as excessive scratching, inflammation and itching around paws, underarms and face. It can be treated by immuno-suppressants, monoclonal anatomy and glucocorticoids. They can be administered through oral, injectables and topical medications. It is known to be highly prevalent in German shepherds, Labradors, golden retrievers and pugs.

Canine Atopic Dermatitis Market Trends:

The increasing occurrence of CAD in domesticated dogs across the globe is one of the key factors creating a positive outlook for the market. This can be attributed to the changing environmental conditions, rising air pollution levels and prolonged exposure to allergens. Moreover, the increasing concerns and rising awareness among pet owners regarding early symptoms and signs of CAD, such as redness, greasy skin and yeasty smell, are providing a thrust to the market growth. Additionally, the widespread adoption of monoclonal antibodies for the treatment of the disease is favoring the market growth. These antibodies aid in directing the required immune response and calming the spread of the disease. In line with this, the increasing number of veterinary practitioners, hospitals and clinics dedicated to providing improved care for animals is positively impacting the market growth. Other factors, including the implementation of various government initiatives to restrict the usage of off-label human drugs on animals, along with extensive research and development (R&D) in the field of veterinary sciences, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global canine atopic dermatitis market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on drug class type, route of administration and distribution channel.

Breakup by Drug Class Type:

  • Glucocorticoids
  • Immunosuppressants
  • Monoclonal Antibody
  • Others

Breakup by Route of Administration:

  • Topical
  • Oral
  • Injectable

Breakup by Distribution Channel:

  • Veterinary Hospitals
  • Pet Clinics
  • Pharmacies and Drugstores
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AB Science, Bimeda Inc., Bioceltix SA, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Phibro Animal Health Corporation, Toray Industries Inc., Vetoquinol S.A., Virbac and Zoetis Inc.

Key Questions Answered in This Report:

  • How has the global canine atopic dermatitis market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global canine atopic dermatitis market?
  • What are the key regional markets?
  • What is the breakup of the market based on the drug class type?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global canine atopic dermatitis market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Canine Atopic Dermatitis Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Class Type

  • 6.1 Glucocorticoids
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Immunosuppressants
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Monoclonal Antibody
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Topical
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Oral
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Injectable
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Veterinary Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pet Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Pharmacies and Drugstores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AB Science
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
    • 14.3.2 Bimeda Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Bioceltix SA
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Boehringer Ingelheim International GmbH
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Ceva Sante Animale
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Dechra Pharmaceuticals PLC
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Elanco Animal Health Incorporated
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Phibro Animal Health Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Toray Industries Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Vetoquinol S.A.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
    • 14.3.11 Virbac
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Zoetis Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Canine Atopic Dermatitis Market: Major Drivers and Challenges
  • Figure 2: Global: Canine Atopic Dermatitis Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Canine Atopic Dermatitis Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Canine Atopic Dermatitis Market: Breakup by Drug Class Type (in %), 2023
  • Figure 5: Global: Canine Atopic Dermatitis Market: Breakup by Route of Administration (in %), 2023
  • Figure 6: Global: Canine Atopic Dermatitis Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Canine Atopic Dermatitis Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Canine Atopic Dermatitis (Glucocorticoids) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Canine Atopic Dermatitis (Glucocorticoids) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Canine Atopic Dermatitis (Immunosuppressants) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Canine Atopic Dermatitis (Immunosuppressants) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Canine Atopic Dermatitis (Monoclonal Antibody) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Canine Atopic Dermatitis (Monoclonal Antibody) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Canine Atopic Dermatitis (Other Drug Class Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Canine Atopic Dermatitis (Other Drug Class Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Canine Atopic Dermatitis (Topical) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Canine Atopic Dermatitis (Topical) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Canine Atopic Dermatitis (Oral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Canine Atopic Dermatitis (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Canine Atopic Dermatitis (Injectable) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Canine Atopic Dermatitis (Injectable) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Canine Atopic Dermatitis (Veterinary Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Canine Atopic Dermatitis (Veterinary Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Canine Atopic Dermatitis (Pet Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Canine Atopic Dermatitis (Pet Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Canine Atopic Dermatitis (Pharmacies and Drugstores) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Canine Atopic Dermatitis (Pharmacies and Drugstores) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Canine Atopic Dermatitis (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Canine Atopic Dermatitis (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: North America: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: North America: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: United States: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: United States: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Canada: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Canada: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Asia-Pacific: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Asia-Pacific: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: China: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: China: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Japan: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Japan: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: India: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: India: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: South Korea: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: South Korea: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Australia: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Australia: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Indonesia: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Indonesia: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Others: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Others: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Europe: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Europe: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Germany: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Germany: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: France: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: France: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: United Kingdom: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: United Kingdom: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Italy: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Italy: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Spain: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Spain: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Russia: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Russia: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Others: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Others: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Latin America: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Latin America: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Brazil: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Brazil: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Mexico: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Mexico: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Others: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Others: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Middle East and Africa: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Middle East and Africa: Canine Atopic Dermatitis Market: Breakup by Country (in %), 2023
  • Figure 78: Middle East and Africa: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Global: Canine Atopic Dermatitis Industry: SWOT Analysis
  • Figure 80: Global: Canine Atopic Dermatitis Industry: Value Chain Analysis
  • Figure 81: Global: Canine Atopic Dermatitis Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Canine Atopic Dermatitis Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Drug Class Type (in Million US$), 2024-2032
  • Table 3: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
  • Table 4: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Canine Atopic Dermatitis Market: Competitive Structure
  • Table 7: Global: Canine Atopic Dermatitis Market: Key Players